Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Chosa ApS
APS
Active
Advertising protection
CVR 43134477
Puggaardsgade 17, 1573
København V
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2022 · 4 years old
5 employees
www.chosa.bio
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Chosa ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
CF
Claus Frisenberg Pedersen
Management
Management
2022
PB
Peter Buhl
Chief Executive Officer
Chief Executive Officer
2022
SV
SH Verwaltungsgesellschaft mbH
Founder
Founder
2022
Former (1)
NG
Neil Goldsmith
Management
Management
2022 – 2025
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Chosa Oncology AB
Individual
100%
100%
2023
Smerud Medical Research International AS
Individual
10–14.99%
10–14.99%
2022
1632 LLP
Individual
5–9.99%
5–9.99%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Chosa ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network